Company intelligence / Profile preview

LCG Bioscience

Cambridge, Cambridgeshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

LCG Bioscience was a specialist Contract Research Organization (CRO) based in the United Kingdom, primarily focused on early-phase clinical research. The company operated a high-specification Phase I clinical pharmacology unit located at Bourn Hall, near Cambridge, where it conducted complex Phase I and early Phase IIa clinical trials. LCG Bioscience provided a comprehensive suite of services including protocol design, volunteer recruitment, and clinical data management, with particular expertise in respiratory and inflammatory indications. In 2010, the company's clinical trial operations were acquired by Richmond Pharmacology, integrating LCG's capabilities into one of the UK's largest Phase I service providers.

Industry: Contract Research Organization

Beyond the preview

Go deeper on LCG Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LCG Bioscience.

Explore the full profile